IMMU-132

Troubled Immunomedics tries again at FDA after rejection
Fierce Biotech
Thu, 12/5/19 - 10:07 am
Immunomedics
IMMU-132
sacituzumab govitecan
FDA
metastatic triple-negative breast cancer
Will Seattle Genetics' Deal With Immunomedics Get Scuttled?
Motley Fool
Mon, 02/13/17 - 10:02 am
Seattle Genetics
Immunomedics
IMMU-132
Immunomedics Kicked Out of Prestigious ASCO Cancer Conference
TheStreet.com
Fri, 06/3/16 - 09:49 am
Immunomedics
triple negative breast cancer
ASCO 2016
IMMU-132
Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Reuters
Mon, 06/9/14 - 09:21 am
IMMU-132
orphan drugs
Immunomedics
pancreatic cancer
Immunomedics says lung cancer drug IMMU-132 gets orphan drug incentives from FDA
Yahoo/AP
Wed, 12/4/13 - 03:43 pm
Immunomedics
IMMU-132
orphan drugs
small cell lung cancer
Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Yahoo/
Fri, 11/8/13 - 09:13 am
IMMU-132
Immunomedics
solid tumors